Smoking raises the risk of colon cancer across multiple measures, with a large meta-analysis of prospective studies finding that heavier, longer-duration smokers face roughly 20 to 50 percent higher colorectal cancer incidence compared with people who never smoked. The link extends well beyond lung cancer headlines: tobacco smoke damages the colon at the DNA level, reshapes the gut microbiome, and drives specific molecular changes in tumors that affect both where the cancer appears and how it behaves after diagnosis. What makes the relationship particularly interesting is how unevenly the risk is distributed, varying by sex, by which side of the colon is involved, and by the molecular fingerprint of the tumor itself.
How Much Does Smoking Raise the Risk?
A systematic review and meta-analysis pooling data from dozens of prospective studies found that all four dose-response variables it examined were tied to colorectal cancer incidence: the number of cigarettes smoked daily, the number of years a person smoked, cumulative pack-years, and how young someone was when they started. An increase of 60 pack-years was associated with about a 50 percent higher risk, and an increase of 40 cigarettes per day was tied to roughly a 38 percent increase.1PubMed. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis These are population-level averages, and individual risk depends on many factors, but the dose-response pattern is consistent: the more you smoke and the longer you smoke, the higher the risk climbs.
A large American Cancer Society study of over a million participants confirmed this gradient for mortality as well, finding that colorectal cancer death rates increased with both the duration of smoking and the average number of cigarettes smoked per day.2JNCI: Journal of the National Cancer Institute. Cigarette Smoking and Colorectal Cancer Mortality in the Cancer Prevention Study II The risk is not limited to a particular stage or type; it spans the full spectrum from precancerous polyps to advanced tumors.
The Sex Divide and Where in the Colon Tumors Appear
One of the more surprising patterns in the research is that smoking does not hit the colon in the same place for men and women. A large prospective study found that male ever-smokers had about a 39 percent higher risk of left-sided (distal) colon cancer compared with male never-smokers but showed no increased risk on the right side. For women, the pattern flipped: female ever-smokers had about a 20 percent higher risk of right-sided (proximal) colon cancer but no elevated risk on the left.3PubMed Central. Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex This matters because right-sided and left-sided colon cancers differ in biology, symptoms, and prognosis. Right-sided tumors tend to be diagnosed later because they cause fewer obvious symptoms like visible rectal bleeding.
A separate large cohort analysis also found that the overall colon cancer increase linked to smoking appeared stronger for women than men: female ever-smokers had about a 19 percent higher overall colon cancer risk, while male ever-smokers had about an 8 percent increase that was not statistically significant on its own. Women in the heaviest smoking categories, defined by the longest duration or highest pack-years, had more than 40 percent higher risk for proximal colon cancer specifically.4Cancer Epidemiology, Biomarkers & Prevention. The Increased Risk of Colon Cancer Due to Cigarette Smoking May Be Greater in Women than Men This sex-site interaction was not explained by differences in how much men and women smoked. The researchers found that even among postmenopausal women, regardless of whether they used hormone therapy, smoking was linked to higher right-colon cancer risk.5American Journal of Epidemiology. Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex
For rectal cancer, the picture shifts again. Both sexes who had ever smoked showed substantially higher rectal cancer risk, with women facing about a 58 percent increase and men about 40 percent.6PubMed Central. Smoking-Related Risks of Colorectal Cancer by Anatomical Subsite and Sex
Smoking and Precancerous Polyps
Before colon cancer develops, abnormal growths called polyps form in the lining of the colon. Smoking is one of the strongest known risk factors for a specific type called serrated polyps, which are increasingly recognized as an important pathway to cancer. Current smokers had about double the risk of serrated polyps compared with never-smokers in a large cohort study, a much stronger association than smoking had with the more familiar conventional adenomas, where the risk increase was roughly 30 percent.7PubMed Central. Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum
A review of multiple studies found even larger risk estimates for certain serrated subtypes. One study reported that current smokers had more than four times the odds of serrated polyps compared with never-smokers, and smoking was consistently linked to sessile serrated adenomas, a subtype considered particularly prone to becoming cancerous.8PubMed Central. Risk factors for serrated polyps of the colorectum Sessile serrated polyps specifically were about 74 percent more common in current smokers in another analysis.9Gut. Modifiable lifestyle factors associated with risk of sessile serrated polyps, conventional adenomas and hyperplastic polyps The serrated pathway matters because these polyps can be flat and hard to spot during colonoscopy, making them easy to miss on routine screening.
What Smoking Does at the Molecular Level
Smoking does not just increase the odds of colon cancer overall. It preferentially drives certain molecular subtypes. A major finding across multiple studies is the link between smoking and a specific pattern of DNA changes called CIMP-high, where groups of genes get silenced through chemical tagging of DNA. Heavy smokers had about twice the odds of developing CIMP-high colon cancer compared with nonsmokers, and the association between smoking and colon cancer was essentially confined to the subset of tumors carrying this molecular signature.10JNCI: Journal of the National Cancer Institute. Association of Smoking, CpG Island Methylator Phenotype, and V600E BRAF Mutations in Colon Cancer
Smoking was also strongly tied to a mutation in the BRAF gene, specifically the V600E mutation, which is found in a subset of colon cancers and is associated with worse outcomes when it appears alongside certain other features. Heavy smokers had about three times the odds of carrying a BRAF V600E mutation in their tumor.11JNCI: Journal of the National Cancer Institute. Association of Smoking, CpG Island Methylator Phenotype, and V600E BRAF Mutations in Colon Cancer A clinical trial population confirmed this pattern, finding that tumors with BRAF V600E mutations were more likely to appear in current or former smokers.12JNCI: Journal of the National Cancer Institute. Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147
The overlap with microsatellite instability, another molecular marker, further sharpens the picture. Current smokers had roughly two to three times the odds of developing MSI-high colorectal cancer compared with never-smokers, a much larger risk increase than for the more common microsatellite-stable tumors.13British Journal of Cancer. Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways Taken together, these findings suggest that smoking preferentially corrupts an epigenetic pathway in the colon, silencing genes through methylation, activating BRAF, and destabilizing the cell’s DNA repair system. That is a specific route to cancer, not just a vague increase in risk.
How the Gut Microbiome Fits In
A newer line of research suggests that cigarette smoke partly drives colon cancer by changing the community of bacteria living in the gut. In animal studies, mice exposed to cigarette smoke developed shifts in their gut bacteria, including an increase in certain harmful species and a decrease in protective ones. These changes were accompanied by higher levels of bile acid metabolites in the colon and activation of cancer-promoting signaling pathways.14PubMed Central. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites
A particularly striking experiment showed that cigarette smoke exposure promoted tumor growth in colon cancer models when the gut microbiome was intact, but failed to do so when the microbiome was depleted with antibiotics.15iScience. Gut microbiome mediates the tumor-promoting effects of cigarette smoke exposure This is still largely animal data, but it opens the possibility that the gut microbiome is not just a bystander but an active middleman between smoking and colon cancer development. Human studies have begun to classify colorectal tumors by their associated microbial signatures, finding that smoking-linked tumors tend to harbor more carcinogenic bacteria and fewer protective species.16PubMed Central. Association of cigarette smoking with risk of colorectal cancer subtypes classified by gut microbiota
Quitting and How Long the Excess Risk Lasts
The good news is that quitting reduces risk, but not overnight. A pooled analysis found that former smokers remained at higher colorectal cancer risk for up to about 25 years after quitting. The timeline also depended on where in the colon the cancer might develop: the excess risk dropped relatively quickly for the proximal colon and rectum after quitting, but for the distal colon, no meaningful decline appeared until about 20 years after cessation.17PubMed Central. A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors That long tail for distal colon cancer is consistent with the molecular findings, suggesting that the epigenetic changes smoking causes are slow to reverse.
A large prospective cohort study offered a clearer quantitative picture: risk of colorectal cancer decreased with more time since quitting and with earlier age at quitting. Former smokers who had quit before age 40 or who had been quit for more than 30 years showed no remaining excess risk.18Cancer Epidemiology, Biomarkers & Prevention. The Association between Cigarette Smoking and Risk of Colorectal Cancer in a Large Prospective Cohort from the United States Separately, the reduction in risk after quitting was most pronounced for the CIMP-high molecular subtype, the very type most strongly linked to smoking in the first place. Even 10 to 19 years of cessation cut the risk of CIMP-high colorectal cancer roughly in half compared with continued smoking.19American Journal of Epidemiology. A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification In other words, quitting specifically reverses the molecular pathway that smoking activates most aggressively.
Smoking After a Colon Cancer Diagnosis
For people already diagnosed with colorectal cancer, smoking status still matters. A pooled analysis of 11 studies found that current smokers with stage I through III disease had about 53 percent worse overall survival compared with never-smokers after adjusting for other factors. The penalty extended to cancer-specific survival as well: current smokers were about 18 percent more likely to die from their colorectal cancer.20PubMed Central. Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies Former smokers who had quit more than 10 years before diagnosis showed only a small residual effect, and that was mostly on non-cancer-related causes of death rather than the cancer itself.
A clinical trial population analysis added a molecular twist: smoking was tied to shorter disease-free survival in patients whose tumors were BRAF wild-type but not in patients with BRAF-mutated tumors.21PubMed Central. Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147 This counterintuitive finding may reflect the fact that BRAF-mutated tumors already carry such aggressive biology that smoking adds little additional prognostic information. By contrast, in tumors without BRAF mutations, the ongoing metabolic and inflammatory effects of smoking appear to meaningfully worsen outcomes.
Implications for Screening and Early-Onset Cases
Colorectal cancer screening typically begins at age 45 in the United States. One study found that heavy, long-term smokers were diagnosed with colorectal cancer at significantly younger ages than never-smokers, leading the authors to suggest that screening should start 5 to 10 years earlier for people with substantial smoking histories.22PubMed Central. Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening While this specific recommendation has not been universally adopted in guidelines, it underscores a point that often gets lost: smoking is not just a cancer cause, it is a cancer accelerator.
The connection also appears in early-onset colorectal cancer, generally defined as cases diagnosed before age 55. Both former and current smokers had higher odds of early-onset disease, with current smokers facing about a 57 percent increased risk. A dose-response relationship held as well: each additional 10 pack-years increased the odds of early-onset colorectal cancer by about 15 percent.23JNCI Cancer Spectrum. Associations of smoking with early- and late-onset colorectal cancer Early-onset colorectal cancer has been rising in many countries, and while no single factor explains the trend, smoking is clearly one modifiable contributor.
Secondhand Smoke and the Workplace
Evidence on secondhand smoke and colon cancer is thinner than for active smoking, but what exists is concerning. A cross-sectional study of nonsmokers and former smokers found that exposure to environmental tobacco smoke in the workplace for more than an hour daily was associated with about 62 percent higher odds of colorectal adenomas after adjusting for confounders. Among former smokers, that figure was even more dramatic: those with the highest workplace secondhand smoke exposure had more than four times the odds of developing an adenoma compared with former smokers who were not exposed at work.24PubMed Central. Association Between Exposure to Exposure to Environmental Tobacco Smoke at the Workplace and Risk for Developing a Colorectal Adenoma: A Cross-Sectional Study This is a single study and the cross-sectional design limits causal conclusions, but it suggests that the colon may be vulnerable to tobacco carcinogens even at the lower doses received by bystanders.
E-Cigarettes and New Nicotine Products
The assumption that switching from cigarettes to e-cigarettes eliminates colon cancer risk is not supported by the emerging animal data. In a mouse model genetically predisposed to colorectal polyps, e-cigarette vapor exposure promoted polyp formation, increased DNA damage, and activated inflammatory pathways and cancer stem cell markers in the colon. Mice exposed to e-cigarettes showed higher levels of DNA strand breaks and suppression of DNA repair enzymes, effects that were comparable in direction (though not always in magnitude) to those seen with conventional cigarette smoke.25Archives of Toxicology. E-cigarettes increase the risk of adenoma formation in murine colorectal cancer model Mice with dual exposure to both e-cigarettes and conventional cigarettes fared worst. This is still preclinical research, and translating mouse polyp counts to human cancer risk is not straightforward, but the findings are a reason for caution. The colon’s exposure to inhaled toxins happens indirectly, through the bloodstream and through swallowed saliva, so even an aerosolized nicotine product can deliver carcinogens to gut tissue.
DNA Damage and the Adduct Evidence
One of the ways tobacco carcinogens cause cancer is by physically binding to DNA, forming structures called adducts that can lead to mutations if not repaired. A study within a large European cohort found that people who later developed colorectal cancer had significantly higher levels of aromatic DNA adducts in their blood years before diagnosis compared with people who stayed cancer-free. Colon cancer cases tended to have slightly higher adduct levels than rectal cancer cases, though the difference between subsites was not statistically significant.26Cancer Epidemiology, Biomarkers & Prevention. Aromatic DNA Adducts and Risk of Gastrointestinal Cancers: A Case–Cohort Study within the EPIC–Spain However, whether these adducts are directly caused by smoking or by other environmental exposures remains uncertain; at least one smaller study found no direct relationship between urinary markers of tobacco smoke exposure and DNA adduct levels in the colon.27PubMed. Carcinogen DNA adducts and the risk of colon cancer: case-control study The disconnect may reflect the complexity of how tobacco carcinogens reach the colon: some arrive through the bloodstream, some through swallowed smoke, and their relative contributions are hard to measure with a single biomarker.
This uncertainty about the precise chemical mechanism does not weaken the epidemiological case, which is strong. It does suggest that smoking affects the colon through multiple overlapping routes, including direct DNA damage, epigenetic silencing of protective genes, and disruption of the gut microbiome, rather than through a single neat pathway.